Do you often give memory boosting 'smart' pills to your
children to increase attention span and memory to stay awake and score high in
exams? Stop this as such drugs pose special risks to the developing brain of
young adults, researchers warn.
Such "smart" drugs are getting more and more
popular owing to peer pressure, stricter academic requirements and the tough
job market.
"But young people who misuse them risk long-term
impairments to brain function," said Kimberly Urban at University of Delaware
and Wen-Jun Gao at Drexel University College of Medicine in the US.
The study found that any
short-term boost in mental performance due to smart drugs may come at a heavy
cost - a long-term decrease in brain plasticity, necessary for task switching,
planning ahead, and adaptive flexibility in behaviour.
Methylphenidate is the most
popular smart drug among kids today.
Trials on rats have shown that
even low dosages of Methylphenidate early in life can reduce nerve activity,
working memory and the ability to quickly switch between tasks and behaviours.
Another popular smart drug is
modafinil, sold under the name Proviigil.
Believed to work by raising the
levels of dopamine in between synapses of brain nerve cells, it can boost
memory as well as the ability to work with numbers and do other mental tasks.
New research indicates that
modafinil could have similar long-term undesired effects as methylphenidate on
the developing brain, researchers noted.
"More research on the
long-term effects of such drugs, especially in young people, is urgently
needed," the authors cautioned in a paper that appeared in the journal
Frontiers in Systems Neuroscience.
No comments:
Post a Comment